Grifols to exhibit at CPhI Worldwide 2017

Published: 29-Sep-2017
Manufacturing

Grifols Partnership is a business to business contract development and manufacturing platform that specialises in small molecules intravenous solutions for the pharmaceutical industry

Grifols Partnership undertakes all commitments with great enthusiasm; its objective is that your product reaches the market on time and in optimum condition.

Technological capabilities include the following:

  • aqueous LVP and SVP
  • emulsion technology
  • form fill seal (FFS) technology for PP bags
  • manufacture and filling of oxygen and light sensitive products
  • terminal sterilisation

Meet Grifols at CPhI WW 2017; stand 41J52 / ZONE ICSE General Floor

  • Companies:
  • Grifols
See more

You may also like

Manufacturing

Spanish technology collaboration focuses on manufacturing equipment

Read more
Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation

Trending Articles

  1. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact they’re having on the pharmaceutical industry
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  5. etherna appoints Shelly West as Business Development Director, US Shelly arrives from Cellpoint Biosciences and will be in charge of expanding etherna's US customer base

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Spanish technology collaboration focuses on manufacturing equipment

Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation
Manufacturing

FOYA projects enhanced with GEA Technology

The company supplies equipment to three winners at the ISPE awards
Manufacturing

Grifols opens US$370m plasma production plant in Clayton, NC in the US

The North Fractionation Facility will produce six million litres of plasma a year by 2015
Manufacturing

2014 ISPE Facility of the Year Awards (FOYA) winners announced

Overall winner will be announced in October in Las Vegas
Manufacturing

WuXi AppTec peptide facility receives PMDA approval

The company's Changzhou oligonucleotide API manufacturing site was approved by Japan's Pharmaceuticals and Medical Devices Agency
Manufacturing

Ardena's nanomedicines facility marks expansion with first GMP approval

The EUR €20m expansion to the nanomedicines facility at Pivot Park has achieved operational status by the Dutch Healthcare Authority
Manufacturing

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

The award recognises employers that create an outstanding experience for employees
Subscribe now